Darrell Triulzi
Pittsburgh, PANPI 1932175593
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,890,974 of the $2,908,398 with a category attached, or 99.4%. Vitalant accounts for 90.3% of it on its own, with 5 other manufacturers making up the rest.
Across 80 payments — averaging $36,355 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vitalant$2.6M
- Institute For Transfusion Medicine$261K
- Fresenius Kabi USA, LLC$17K
- Terumo BCT, Inc.$3K
- Werfen USA LLC$186
- Cerus Corporation$74
Across 12 payments — averaging $4965.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Institute For Transfusion Medicine$60K
What the payments were for
- Consulting fees$16,9341%
- Speaking & faculty fees$2,890,97499%
- Food & beverage$4030%
- Gifts$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vitalant | 56 | $2,627,351 |
| Institute For Transfusion Medicine | 5 | $260,823 |
| Fresenius Kabi USA, LLC | 14 | $17,163 |
| Terumo BCT, Inc. | 1 | $2,800 |
| Werfen USA LLC | 2 | $186 |
| Cerus Corporation | 2 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MD-Amicus$8,890
- Spectra Optia Apheresis System$2,800
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.